Direxion Daily Pharmaceutical & Medical Bull 3X ETF (NYSEARCA:PILL – Get Free Report) saw a large decline in short interest in the month of September. As of September 30th, there was short interest totaling 17,878 shares, a decline of 52.0% from the September 15th total of 37,247 shares. Based on an average trading volume of 45,224 shares, the days-to-cover ratio is presently 0.4 days. Approximately 1.6% of the company’s shares are sold short.
Direxion Daily Pharmaceutical & Medical Bull 3X ETF Stock Down 6.6%
PILL stock traded down $0.94 during trading on Friday, hitting $13.38. The company had a trading volume of 46,357 shares, compared to its average volume of 80,153. The firm has a market capitalization of $14.71 million, a P/E ratio of 10.33 and a beta of 1.79. The company has a 50 day simple moving average of $18.72 and a 200-day simple moving average of $16.04. Direxion Daily Pharmaceutical & Medical Bull 3X ETF has a 52-week low of $7.74 and a 52-week high of $24.15.
About Direxion Daily Pharmaceutical & Medical Bull 3X ETF
The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. The fund provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US. PILL was launched on Nov 15, 2017 and is managed by Direxion.
Further Reading
- Five stocks we like better than Direxion Daily Pharmaceutical & Medical Bull 3X ETF
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
- Palantir’s Potential Next Catalyst After Retail Profit-Taking
- Morgan Stanley Beats on Earnings, But Shares Fall on Trading Mix
Receive News & Ratings for Direxion Daily Pharmaceutical & Medical Bull 3X ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily Pharmaceutical & Medical Bull 3X ETF and related companies with MarketBeat.com's FREE daily email newsletter.
